A hybrid process-based and statistical modeling approach to dynamically predict quality parameters of industrial hemp, such as fiber quality and cannabinoid content, in-season. Enables better management of quantity-quality trade-offs driven by genotype, environment, and agronomic practices.
This solution addresses a critical gap in industrial hemp production: the lack of in-season, dynamic prediction of crop quality traits such as fiber quality and cannabinoid content. While existing crop growth models can forecast yield quantity, most do not capture quality parameters that are increasingly important for nutrition, regulatory compliance, and industrial applications. By combining process-based crop modeling with statistical and AI-driven approaches, this platform provides a more timely and accurate understanding of how environmental, genetic, and agronomic factors drive hemp quality. The result is improved decision-making around the quantity-quality dynamics that determine both regulatory compliance and profitability.
Modeling approach:
Validation strategy:
This research is at an early-to-mid development stage. The underlying methodology of combining process-based and statistical modeling has been validated in other crops, but direct validation for hemp remains ongoing. Previous hemp agronomic studies confirm significant variability in quality parameters across cultivars, environments, and management practices, underscoring the need for predictive tools. The team is actively seeking partnerships to support model development and fund experimental supplies and lab testing. Once validated, this platform could provide hemp growers and processors with actionable, in-season quality forecasts to optimize both regulatory compliance and market returns.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.